Effect of fluticasone on neuropeptides in nasal lavage in persistent allergic rhinitis

Journal of Investigational Allergology and Clinical Immunology

Volumn 20, Issue 3, 2010, Pages 214-221

  Schaper C ^a   Gustavus, B ^b   Koch, B ^a   Ewert, R ^a   Felix, S B ^a   Kunkel, G ^b   Noga, O ^a   Glaser S ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Allergen challenge; Fluticasone propionate; Nasal lavage; Neurogenic inflammation; Neurokinin A.; Persistent allergic rhinitis; Substance P; Vasoactive intestinal peptide

Indexed keywords

FLUTICASONE PROPIONATE; HISTAMINE; IMMUNOGLOBULIN E; NEUROKININ A; NEUROPEPTIDE; SERUM ALBUMIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; ATOPY; CLINICAL ARTICLE; CONTROLLED STUDY; DERMATOPHAGOIDES; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; MALE; NASAL LAVAGE; PERENNIAL RHINITIS; PROTEIN FUNCTION; PROTEIN SECRETION; RHINOMANOMETRY; SYMPTOMATOLOGY;

ADULT; AGED; ANDROSTADIENES; ANTI-ALLERGIC AGENTS; ANTIGENS, DERMATOPHAGOIDES; FEMALE; HISTAMINE; HUMANS; MALE; MIDDLE AGED; NASAL LAVAGE FLUID; NEUROKININ A; RHINITIS, ALLERGIC, PERENNIAL; SERUM ALBUMIN; STATISTICS, NONPARAMETRIC; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE; YOUNG ADULT;

EID: 77954363064     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, Zuberbier T, Baena-Cagnani CE, Anonica GW, van Weel C, Agache I, Ait-Khaled N, Bachert C, Blaiss MS, Bonini S, Boulet LP, Bousquet PJ, Camargos P, Carlsen KH, Chen Y, Custovic A, Dahl R, Demoly P, Douagui H, Durham SR, van Wijk RG, Kalayci O, Kaliner MA, Kim YY, Kowalski ML, Kuna P, Le LT, Lemiere C, Li J, Lockey RF, Mavale-Manuel S, Meltzer EO, Mohammad Y, Mullol J, Naclerio R, O'Hehir RE, Ohta K, Ouedraogo S, Palkonen S, Papadopoulos N, Passalacqua G, Pawankar R, Popov TA, Rabe KF, Rosado-Pinto J, Scadding GK, Simons FE, Toskala E, Valovirta E, van Cauwenberge P, Wang DY, Wickman M, Yawn BP, Yorgancioglu A, Yusuf OM, Zar H, Annesi-Maesano I, Bateman ED, Ben Kheder A, Boakye DA, Bouchard J, Burney P, Busse WW, Chan-Yeung M, Chavannes NH, Chuchalin A, Dolen WK, Emuzyte R, Grouse L, Humbert M, Jackson C, Johnston SL, Keith PK, Kemp JP, Klossek JM, Larenas-Linnemann D, Lipworth B, Malo JL, Marshall GD, Naspitz C, Nekam K, Niggemann B, Nizankowska-Mogilnicka E, Okamoto Y, Orru MP, Potter P, Price D, Stoloff SW, Vandenplas O, Viegi G, Williams D. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63 Suppl 86:8-160.
2. Barnes PJ. Neuropeptides in the lung: localization, function, and pathophysiologic implications. J Allergy Clin Immunol. 1987;79:285-295.
3. Fischer A, Wussow A, Cryer A, Schmeck B, Noga O, Zweng M, Peiser C, Dinh QT, Heppt W, Groneberg DA. Neuronal plasticity in persistent perennial allergic rhinitis. J Occup Environ Med. 2005;47:20-25.
4. Pfaar O, Raap U, Holz M, Hormann K, Klimek L. Pathophysiology of itching and sneezing in allergic rhinitis. Swiss Med Wkly.2009 24;139: 35-40.
5. Lundblad L, Lundberg JM, Brodin E, Anggard A. Origin and distribution of capsaicin-sensitive substance P-immunoreactive nerves in the nasal mucosa. Acta Otolaryngol. 1983;96:485-493.
6. Baraniuk JN, Lundgren JD, Okayama M, Goff J, Mullol J, Merida M, Shelhamer JH, Kaliner MA. Substance P and neurokinin A in human nasal mucosa. Am J Respir Cell Mol Biol. 1991;4:228-236.
7. Baraniuk JN, Lundgren JD, Okayama M, Mullol J, Merida M, Shelhamer JH, Kaliner MA. Vasoactive intestinal peptide in human nasal mucosa. J Clin Invest. 1990 Sep;86(3):825-831.
8. Undem BJ, McAlexander M, Hunter DD. Neurobiology of the upper and lower airways. Allergy. 1999;54 Suppl 57:81-93.
9. Joos GF, Germonpre PR, Pauwels RA. Role of tachykinins in asthma. Allergy. 2000;55:321-337.
10. Forsythe P, McGarvey LP, Heaney LG, MacMahon J, Ennis M. Sensory neuropeptides induce histamine release from bronchoalveolar lavage cells in both nonasthmatic coughers and cough variant asthmatics. Clin Exp Allergy. 2000;30:225-32.
11. Barnes PJ. Asthma as an axon reflex. Lancet. 1986 Feb 1; 1(8475):242-245.
12. Koehne P, Schaper C, Graf K, Kunkel G. Neutral endopeptidase 24.11: its physiologic and possibly pathophysiologic role in inflammation with special effect on respiratory inflammation. Allergy. 1998;53:1023-1042.
13. Malm L, Sundler F, Uddman R. Effects of vasoactive intestinal polypeptide on resistance and capacitance vessels in the nasal mucosa. Acta Otolaryngol. 1980;90:304-8.
14. Said SI. VIP as a modulator of lung inflammation and airway constriction. Am Rev Respir Dis. 1991;143:S22-24.
15. Baumgarten CR, Witzel A, Kleine-Tebbe J, Kunkel G. Substance P enhances antigen-evoked mediator release from human nasal mucosa. Peptides. 1996;17:25-30.
16. Shinoda M, Watanabe N, Suko T, Mogi G, Takeyama M. Effects of anti-allergic drugs on substance P (SP) and vasoactive intestinal peptide (VIP) in nasal secretions. Am J Rhinol. 1997 May-Jun;11:237-241.
17. Heaney LG, Cross LJ, McGarvey LP, Buchanan KD, Ennis M, Shaw C. Neurokinin A is the predominant tachykinin in human bronchoalveolar lavage fluid in normal and asthmatic subjects. Thorax. 1998;53:357-62.
18. Vaidyanathan S, Barnes M, Lipworth BJ. Comparative safety and efficacy of 2 formulations of fluticasone aqueous nasal spray in persistent allergic rhinitis. Ann Allergy Asthma Immunol. 2009;102:76-83.
19. Baumgarten CR, O'Connor A, Dokic D, Schultz KD, Kunkel G. Substance P is generated in vivo following nasal challenge of allergic individuals with bradykinin. Clin Exp Allergy. 1997;27:1322-1327.
20. Siraganian RP. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem. 1974;57:383-394.
21. Kim D, Baraniuk JN. Neural aspects of allergic rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2007;15:268-273.
22. Naclerio RM, Proud D, Togias AG, Adkinson NF, Jr., Meyers DA, Kagey-Sobotka A, Plaut M, Norman PS, Lichtenstein LM. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 11;313:65-70.
23. Kulka M, Sheen CH, Tancowny BP, Grammer LC, Schleimer RP. Neuropeptides activate human mast cell degranulation and chemokine production. Immunology. 2008;123:398-410.
24. Raphael GD, Baraniuk JN, Kaliner MA. How and why the nose runs. J Allergy Clin Immunol. 1991;87:457-467.
25. Nieber K, Baumgarten C, WitzelA, Rathsack R, Oehme P, Brunnee T, Kleine-Tebbe J, Kunkel G. The possible role of substance P in the allergic reaction, based on two different provocation models. Int Arch Allergy Appl Immunol. 1991;94:334-8.
26. Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol. 1993;92:95-104.
27. Walker KB, Serwonska MH, Valone FH, Harkonen WS, Frick OL, Scriven KH, Ratnoff WD, Browning JG, Payan DG, Goetzl EJ. Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen. J Clin Immunol. 1988;8:108-13.
28. Tonnesen P, Hindberg I, Schaffalitzky de Muckadell OB, Mygind N. Effect of nasal allergen challenge on serotonin, substance P and vasoactive intestinal peptide in plasma and nasal secretions. Allergy. 1988;43:310-7.
29. Okamoto Y, Shirotori K, Kudo K, Ishikawa K, Ito E, Togawa K, Saito I. Cytokine expression after the topical administration of substance P to human nasal mucosa. The role of substance P in nasal allergy. J Immunol. 1993 15;151:4391-4398.
30. Graf K, Schaper C, Grafe M, Fleck E, Kunkel G. Glucocorticoids and protein kinase C regulate neutral endopeptidase 24.11 in human vascular smooth muscle cells. Basic Res Cardiol. 1998;93:11-7.
31. Adcock IM, Peters M, Gelder C, Shirasaki H, Brown CR, Barnes PJ. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinol. 1993;11:1-7.
32. Erin EM, Zacharasiewicz AS, Nicholson GC, Tan AJ, Higgins LA, Williams TJ, Murdoch RD, Durham SR, Barnes PJ, Hansel TT. Topical corticosteroid inhibits interleukin-4, -5 and -13 in nasal secretions following allergen challenge. Clin Exp Allergy. 2005;35:1608-1614.
33. Baroody FM, Shenaq D, Detineo M, Wang J, Naclerio RM. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009;123:1342-8